New product launch: UltraBLIS(TM)

New product launch: UltraBLIS(TM) Dunedin based Blis Technologies has launched a new product UltraBLIS which is a unique combination of BLIS K12(TM) with two gut probiotic strains. UltraBLIS is a next generation probiotic supplement targeted at those wanting to optimise their microbiome and strengthen overall immunity. BLIS K12 has strong evidence in the oral microbiome, and it has been combined in a lozenge format with Bifidobacterium lactis HN019 (HOWARU(R)), and Lactobacillus acidophilus La-14: 2 strains from Dupont(R) that have strong evidence bases in immunity. The product will initially be available exclusively online from www.ultrablis.co.nz with planning for a NZ retail launch underway. For more information on the product and for purchase please visit www.ultrablis.co.nz. Ends For further information, please contact: Julie Curphey Chief Marketing Officer +64 21 344 527 About Blis Technologies Ltd Delivering proven health benefits through evidence-based, advanced probiotics Blis is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support and teeth and gum health. BLIS products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz. End CA:00347836 For:BLT Type:GENERAL Time:2020-02-03 09:59:19